Covid 19

Introduction

Last Updated: February 11, 2021

The COVID-19 Treatment Guidelines have been developed to provide clinicians with guidance on how to care for patients with COVID-19. Because clinical information about the optimal management of COVID-19 is evolving quickly, these Guidelines will be updated frequently as published data and other authoritative information become available.

Panel Composition

Members of the COVID-19 Treatment Guidelines Panel (the Panel) are appointed by the Panel co-chairs based on their clinical experience and expertise in patient management, translational and clinical science, and/or development of treatment guidelines. Panel members include representatives from federal agencies, health care and academic organizations, and professional societies. Federal agencies and professional societies represented on the Panel include:

• American Association of Critical-Care Nurses 
• American Association for Respiratory Care
• American College of Chest Physicians 
• American College of Emergency Physicians 
• American College of Obstetricians and Gynecologists 
• American Society of Hematology 
• American Thoracic Society 
• Biomedical Advanced Research and Development Authority 
• Centers for Disease Control and Prevention 
• Department of Defense 
• Department of Veterans Affairs 
• Food and Drug Administration 
• Infectious Diseases Society of America 
• National Institutes of Health 
• Pediatric Infectious Diseases Society 
• Society of Critical Care Medicine 
• Society of Infectious Diseases Pharmacists